Alfuzosin Hcl
1 NDC across 1 manufacturer|0 Generic,1 Brand
Alfuzosin Hcl is used to treat prostatic hyperplasia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $26 million on Alfuzosin Hcl across 1.1 million claims for 310,000 beneficiaries.
Alfuzosin Hcl is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $18.33 to $18.33 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$18.33 – $18.33
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing ALFUZOSIN HCL
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
UROXATRAL 10 MG TABLET | $18.3338 per EA | — |
Frequently Asked Questions
What is Alfuzosin Hcl used to treat?
Alfuzosin Hcl is used to treat prostatic hyperplasia, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Alfuzosin Hcl?
In 2024, Medicare Part D spent $26 million on Alfuzosin Hcl across 1.1 million claims for 310,000 beneficiaries.
How many Alfuzosin Hcl products are on the market?
The Alfuzosin Hcl drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Alfuzosin Hcl?
NADAC reference prices for Alfuzosin Hcl range from $18.3338 to $18.3338 per EA.
Which manufacturers make Alfuzosin Hcl?
1 manufacturer lists Alfuzosin Hcl in NADAC. Ranked by number of NDCs, the largest are Advanz Pharma (US) Corp. (1).